logo
The Prototype: New Bacteria Discovered On Chinese Space Station

The Prototype: New Bacteria Discovered On Chinese Space Station

Forbes23-05-2025
In this week's edition of The Prototype, we look at whether we should worry about spaceborne bacteria, a clinical trial for regenerating nerves after a traumatic injury, a new class of electronics and more. You can sign up to get The Prototype in your inbox here.
A Chinese spacecraft returning from the Tiangong space station
A previously unknown strain of bacteria is living on Chain's Tiangong space station, according to a study published this week. The new microorganisms were discovered on swabs taken from the station. The news immediately brought the novel (and movie) The Andromeda Strain into my brain, which is about a disease that makes it to Earth from space by way of a government satellite.
Luckily, Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security, reassured me that any microorganisms found in space aren't likely to cause a new pandemic. 'It's important to remember that the vast, vast majority of bacterial organisms are not going to cause any harm,' he said.
One thing to consider about these types of microbes, he said, is that their ability to adapt to one extreme environment does not mean they will thrive in another environment that it's not adapted to.' And to determine whether such an organism might pose a disease risk, it's important to consider whether they can survive in human bodies. If they can, do they even cause any harm? Odds are, they don't, he said. 'Most bacteria that live on or in us aren't harmful,' he said.
Even if a new microorganism adapted to space or some other environment were to cause disease, humans still wouldn't necessarily be helpless, Adalja said. That's because lots of microorganisms share characteristics with each other, meaning the study of a new pathogen's data, like its DNA, can help researchers determine ways to find a treatment or vaccine.
Stay tuned.
Auxilium Biotechnologies
Over 300,000 people every year experience an accident that causes damage to their peripheral nerves–those that exist outside of the brain and spinal cord. These injuries can be serious and lead to disability in some cases. There's no easy way to treat them, either. When repairs are possible, they often require surgically grafting a portion of a healthy nerve from another part of the body to the injured one. Sometimes that canlead to difficult complications and side effects like chronic pain.
San Diego-based Auxilium Biotechnologies has a different approach. It's developed a device it calls a NeuroSpan Bridge, which it hopes will enable damaged nerves to regenerate into health. It does this by physically guiding the nerves to grow in a single direction to repair the damage. The company announced this week that it will begin a clinical trial of 80 nerve trauma patients with its device.
Nerves do actually regenerate naturally, CEO and cofounder Jacob Koffler, who is also a professor of neuroscience at UC San Diego, told me. But the problem is that 'the nerve goes wherever it wants,' he said. It doesn't necessarily reconnect with the rest of the healthy nerve. 'What we bring to the table is a technology that organizes regeneration' by guiding the regenerated nerves directly to the healthy one. The company has already successfully demonstrated the device in mice, so humans are the next step.
The clinical trial will take about a year, Koffler said. If results are good, the company would then work to seek a green light from the FDA to commercialize its device.
Scientists at Rutgers University have created 'intercrystals' - a new substance that could power the electronics of the future. It consists of two layers of graphene, each one atom thick, which are laid on top of a crystal made from boron and nitrogen. The result is a structural pattern in the chemistry that allows a very efficient transmission of electrons that can be refined on the atomic level. The researchers behind the discovery say it could someday lead to more efficient electronics materials such as sensors or transistors. Even more importantly–all the components are cheap. 'Because these structures can be made out of abundant, non-toxic elements such as carbon, boron and nitrogen, rather than rare earth elements, they also offer a more sustainable and scalable pathway for future technologies,' researcher Eva Andrei said in a press release about the discovery.
NASA says that a 'cumulative multi-year budget reduction' will force cutbacks in crew size and scientific research on board the International Space Station. NASA is currently considering operating the U.S. portion of the station with a three person crew, rather than four. There are also fewer planned cargo flights to the International Space Station, which will reduce revenues for contractors like SpaceX and Northrop Grumman. It's not clear yet whether NASA will be able to continue to support private missions to the ISS, such as those from SpaceX purchased by Axiom Space.
I wrote about Abel Avellan, whose company AST SpaceMobile is taking on SpaceX and Jeff Bezos' Project Kuiper in the battle to provide broadband satellite internet directly to your smartphone. This would enable connectivity in remote areas and help the over 2.6 billion people who currently lack regular internet access o get online.
In my other newsletter, InnovationRx, Amy Feldman and I looked at the FDA's new COVID-19 vaccine rules, Novartis's acquisition strategy, Medtronic's diabetes spinoff, Regeneron's purchase of 23AndMe, and more.
Recycling electronics might get easier thanks to researchers at the University of Helsinki, who figured out a way to extract silver from old electronics with used cooking oil.
Funding for scientific research is at its lowest point in 35 years, reports the New York Times, with nearly every field being impacted by the slowdown in grants from the National Science Foundation.
Energy infrastructure projects tend to be over budget and behind schedule, a new study finds. Nuclear power plants are the worst offenders. If you want the best bang for your energy investment buck, build a solar power project–they tend to finish under budget or ahead of schedule.
Researchers built a new kind of lithium battery that works by pulling carbon dioxide out of the atmosphere. Previous attempts at this kind of chemistry tended to be expensive and not work well, but the new version could allow them to scale cheaply. And good news for Elon Musk–they're ideal for Mars, where the atmosphere is 95% carbon dioxide.
One of the downfalls of restrictive dieting to lose weight is that pretty soon you start craving certain foods–and once you give in after prolonged abstinence, you may start binging, which can derail your diet completely. A new study suggests a better way: eat what you crave. During the study, a group of people on a diet were encouraged to include the foods they love, even junk food, into otherwise balanced meals. That group of people not only lost more weight, they also reported fewer food cravings than those who didn't incorporate such foods into their meal plans.
One of the comforts of the streaming era is the chance to finally get around to shows that you missed the first time. Right now, for example, I'm watching Boardwalk Empire, which aired on HBO from 2009 to 2014. The series is centered on organized crime and corruption in Atlantic City during the Prohibition era, using real-life characters like Al Capone, Lucky Luciano and Meyer Lansky. Steve Buscemi is excellent in the lead role and it's a great watch for anyone who's into a good mob drama. All episodes are streaming on Max–or HBO Max–or whatever we're calling it now.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Diabetes Tech Use On the Rise But A1c Reductions Still Lag
Diabetes Tech Use On the Rise But A1c Reductions Still Lag

Medscape

time41 minutes ago

  • Medscape

Diabetes Tech Use On the Rise But A1c Reductions Still Lag

Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open . Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains. 'Additional opportunities for individualized patient and clinician education can help optimize the use of technologies. In our analyses, the increase in CGM and insulin pump use substantially outpaced gains in glycemic control,' Fang and colleagues wrote. In an accompanying editorial, Diana Soliman, MD, of the Division of Endocrinology at the University of Miami Miller School of Medicine in Miami, and colleagues wrote, 'As technological innovation continues to accelerate, it is encouraging to see signs of progress in glycemic management. Ensuring that these advances benefit all individuals with T1D must remain a priority.' Asked to comment, Anne L. Peters, MD, professor of clinical medicine and director of Clinical Diabetes Programs at the Keck School of Medicine of USC, Los Angeles, told Medscape Medical News that a key component is having staff to help with prior authorization paperwork and certified diabetes care and education specialists (CDCES) to help train patients and troubleshoot. 'These health disparities are real but fixable. However, it takes staff to make it happen.' Tech Use On the Rise But A1c Level Hasn't Dropped Much Fang and colleagues used the OptumLabs Data Warehouse to identify 186,590 eligible individuals with T1D, of whom 26,853 were younger than 18 years. Three quarters were White, 12% were Black, and 7% were Hispanic individuals. Few previous studies of T1D have included such representative population-based data, the authors noted. From 2009-2011 to 2021-2023, among youths, the use of CGMs rose from 4% to 82%, insulin pumps from 16% to 50%, and the combination from 1% to 47% ( P for trend < .001 for all). Such use in 2021-2023 was higher among White youths and those with commercial insurance. During the same period, among adults, the use of CGM rose from 5% to 57%, insulin pumps from 11% to 29%, and the combination from 1% to 22% ( P for trend < .001 for all). Throughout, adults who were White, younger, and commercially insured were more likely to use CGMs. Overall, mean A1c levels dropped from 8.9% to 8.3% in youths and from 8.2% to 8.0% in adults from 2009-2011 to 2021-2023. Among youths, the prevalence of achieving glycemic control, defined as an A1c level < 7%, rose from about 7% in 2009-2011 and 2014-2017 to 19% in 2021-2023 ( P for trend < .001). Glycemic control improved for all youth subgroups except for Black youths. Differences by race, ethnicity, and insurance type increased after 2018-2020. During 2021-2023, 21% of White youths vs 17% of Hispanic and 12% of Black youths achieved glycemic control. Those with commercial health insurance also had higher rates of glycemic control than those with Medicaid insurance (22% vs 13%). For adults with T1D, glycemic control rose from 21% in 2009-2011 to 28% in 2021-2023 ( P for trend < .001). Again, the prevalence of achieving glycemic control was higher among those who were White (30% vs 20% of Hispanic and 21% of Black patients in 2021-2023) and those who had commercial insurance (30% vs 19% of those who had Medicaid insurance). Implications for Clinical Practice These findings have important implications for clinical practice and policy, Soliman and colleagues said. 'Barriers to diabetes technology access, including financial costs, lack of clinician prescription, and inadequate clinical communication, continue to disproportionately affect medically underserved populations. While the increase in diabetes technology may be attributed to expanded insurance coverage, incorporation into guidelines, and improved technology, there remains a crucial need to extend this technology more widely.' Addressing these challenges, they said, 'requires coordinated efforts that combine reduced financial barriers with clinician training, shared decision-making, and culturally competent communication to promote equitable and effective use of technology.' Peters has one practice in the relatively wealthy west side of Los Angeles and another in an underserved area in East Los Angeles. On the west side, she has a full-time staffer who exclusively handles prior authorizations for diabetes devices and a CDCES who trains patients and follows them weekly. The patients there all speak English and have high health literacy. On the east side, there aren't any educators and no classes on advanced technology. A prescription for an automated insulin delivery device can take months to get filled. Non-English speaking patients may have difficulty accessing manufacturer assistance and may lack smartphones compatible with their devices. Even when patients are able to start using the technology, they may not have the support they need to continue. 'The systems of care often lack what it takes to provide adequate care for under-resourced people with T1D. When we've had research funding to provide a CDCES, my patients in East LA do great. The training often takes longer than in those who are starting at a higher knowledge level, but technology is very useable by under-resourced people,' Peters said. The study was funded by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases. Fang had no other disclosures. Soliman had no disclosures. Peters reported recording videos for Medscape Medical News, being on the advisory board for Vertex, and having stock options for Omada Health.

Erectile Function After Prostate Radiation: How MRI May Help
Erectile Function After Prostate Radiation: How MRI May Help

Medscape

time41 minutes ago

  • Medscape

Erectile Function After Prostate Radiation: How MRI May Help

TOPLINE: Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated 'classic' neurovascular bundle patterns and over 96% showed more than 1-cm separation of internal pudendal arteries from the prostate. These findings indicated that most patients have favorable anatomic patterns that would allow radiation oncologists to minimize radiation to structures involved in erectile function and help reduce patients' risk for posttreatment erectile dysfunction. METHODOLOGY: Erectile dysfunction is a common side effect for men with prostate cancer who undergo SABR. Radiation-related damage to critical nearby structures, such as the neurovascular bundles and internal pudendal arteries, likely contributes to this issue. Identifying these structures on MRI during radiation planning can minimize exposure during SABR and reduce the risk for erectile dysfunction. Researchers analyzed 160 consecutive patients with prostate cancer (median age, 70 years) who underwent MRI-linear accelerator-based SABR between January and December 2024. Based on the MRI scans, researchers classified neurovascular bundle patterns into classic (discrete), adherent (dispersed and adherent to the prostatic capsule), or absent. Researchers also measured the shortest distance between internal pudendal arteries to the prostate capsule and the membranous urethral length and compared imaging features by prostate volumes, Prostate Imaging Reporting and Data System (PI-RADS) scores, lesion locations, and Gleason grade group. TAKEAWAY: The classic neurovascular bundle pattern was the most common, present in 80% of right-sided and 85% of left-sided evaluations, while adherent neurovascular bundles were less common, observed in 18.1% of right-sided and 13.8% of left-sided scans. The median shortest distance between internal pudendal arteries and the prostate capsule was 2.3 cm on both sides, with only 3.1% (left side) to 3.8% (right side) of patients having a distance less than 1.0 cm. The median membranous urethral length was 1.5 cm, with only 2.5% of men having one shorter than 1.0 cm. Researchers found no significant association between these MRI features and prostate volumes of greater or less than 40 mL, PI-RADS scores, zonal location of the dominant intraprostatic lesion, and Gleason grade on pathology. IN PRACTICE: 'Most patients with prostate cancer undergoing SABR demonstrated favorable anatomy of the critical structures, potentially important for potency preservation,' the authors wrote, reflecting on the fact that real-time adaptive planning, especially with MRI-guided radiotherapy, has potential for helping 'identify, define, and effectively dose-constrain these critical structures.' SOURCE: The study, led by Sungmin Woo, MD, PhD, NYU Grossman School of Medicine in New York City, was published online in Practical Radiation Oncology. LIMITATIONS: The study was conducted at a single institution, which may limit the generalizability of the findings. Additionally, the analysis excluded patients with prior prostate-directed treatments, artifacts on MRI scans, and extraprostatic extension or those without diagnostic multiparametric MRI scans, restricting applicability to patients with more advanced disease or suboptimal imaging. DISCLOSURES: This study did not receive any specific funding. One author disclosed serving as a consultant for Boston Scientific. The other authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

NASA launches second phase of moon recycling competition
NASA launches second phase of moon recycling competition

Yahoo

timean hour ago

  • Yahoo

NASA launches second phase of moon recycling competition

Aug. 11 (UPI) -- NASA is launching the second phase of its moon recycling competition to clean up trash in space. The space agency's LunaRecycle Challenge is looking for the brightest minds to figure out a way to recycle plastics, foams and metals left behind by ongoing activity and building in space. "NASA is eager to see how reimagining these materials can be helpful to potential future planetary surface missions," said Jennifer Edmunson, acting program manager for Centennial Challenges at NASA's Marshall Space Flight Center in Alabama. "I'm confident focusing on the most critical trash items -- and integration of the prototype and digital twin competition tracks -- will yield remarkable solutions," Edmunson added, "that could enable a sustainable human presence off-Earth and transform the future of space exploration." As the United States discusses replacing the International Space Station and placing a small nuclear reactor on the moon, the potential for increased waste in space is growing. LunaRecycle's Phase 1 competition attracted record-breaking interest with more than 1,200 registrations. Seventeen teams, from five countries and nine U.S. states, were named winners in that challenge. For Phase 2, only U.S. individuals and teams may participate and must build a physical prototype to manage a year's worth of trash. The challenge estimates a crew of four astronauts would produce more than 4,600 pounds of single-use waste to include food packaging and discarded clothing. The goal for competitors is to recycle the waste, while minimizing crew time and any hazards. Submissions for NASA's LunaRecycle milestone round, which is being administered by the University of Alabama, are open now and due January 2026. Finalists from that round will be announced in February with up to 20 finalists competing in the challenge's in-person prototype demonstrations next August. Successful solutions in both rounds could net winners cash prizes totaling $2 million. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store